안녕하십니까 HK이노엔 IR팀입니다.
prnewswire.com
Sebela Pharmaceuticals® Announces Submission of New Drug Application to FDA for Tegoprazan for the Treatment of Gastroesophageal Reflux Disease
Key Highlights: Sebela Pharmaceuticals® submitted its New Drug Application (NDA) for tegoprazan on January 9, 2026. The NDA seeks approval for three...
